Owner Pfizer Inc.

Inventors Dooley, David J.; Field, Mark John; Williams, Richard Griffith

Agent Allens Arthur Robinson

Pub. Number AU-A-2011200717

Parent 2004271800

Filing date 21 February 2011

Wipo publication date 10 March 2011

A61K 31/136 (2006.01) - having the amino group directly attached to the aromatic ring, e.g. benzeneamine

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/196 (2006.01)

A61K 31/197 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents